PROGRAM |
DISCIPLINE |
HEALTH THEMES |
|
|---|---|---|---|
| Disease Elimination | Public Health | Hepatitis B |
Hepatitis B infection affects over 292 million people worldwide and is a major public health issue. Without timely treatment, chronic hepatitis B infection can cause death from liver damage and liver cancer, and hepatitis B is the lead cause of liver cancer and liver-related deaths worldwide.
Due to the global scale of public health impact from hepatitis B, the World Health Organization (WHO) has set hepatitis B elimination targets to be achieved by 2030 to increase diagnosis, linkage to care and treatment rates for people living with hepatitis B. However, there are currently major barriers to achieving these goals within Australia.
Burnet Institute’s Hepatitis B Elimination program takes a multifaceted approach to achieve hepatitis B elimination in Australia through research projects addressing key goals of the WHO global elimination program.
These projects include:
- mathematical modelling of cost effectiveness and impact of interventions on hepatitis B elimination targets and liver cancer
- epidemiology and surveillance data analysis to understand the hepatitis B epidemic in Australia, including liver cancer.
Contact
Associate Professor Jess Howell
Senior Research Fellow
jess.howell@burnet.edu.au
Associate Professor Nick Scott
Head, Modelling & Biostatistics
nick.scott@burnet.edu.au
More Student Projects
burnet.edu.au/studentprojects
View projects
Why study at Burnet?
When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.
Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.
Find out more Student Projects